FOXM1 and ovarian carcinoma: Although FOXM1 was originally identified as being frequently deregulated in serous ovarian carcinomas, the predominant histotype [4], a subsequent study demonstrated that FOXM1 was similarly overexpressed in non-serous (clear cell and endometrioid) ovarian carcinomas as well as in serous ones [13].